Why Catalent Stock Was in the Red Again Today
CATALENT, INC. INVESTORS: April 25, 2023 Filing Deadline in Securities Class Action – Contact Lieff Cabraser
Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Catalent, Inc. (CTLT) Investors and Encourages Investors to Contact the Firm Before April 25, 2023
CTLT INVESTOR NEWS: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Catalent, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CTLT
Catalent (CTLT) News Update: Johnson Fistel Urges Shareholders to Join Class Action Lawsuit and Provides New Update
Why Catalent Stock Dove More Than 7% Today
CATALENT 96 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Catalent, Inc. - CTLT
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Catalent, Inc. (CTLT)
Why Catalent Stock Tumbled by Nearly 6% on Tuesday
Catalent Recommends Stockholders Reject Mini-Tender Offer From TRC Capital Investment Corporation
Why Wall Street Took a Hit From These 2 NYSE Stocks
Why Catalent Stock Was a Disaster Today
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Catalent, Inc. (CTLT)
Why Shares of Catalent Were Up Friday
Why Catalent Stock Could Only Inch Higher Today
Earnings Summary: A snapshot of Catalent’s Q3 2023 results
CATALENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Catalent, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Why Catalent Stock Flopped Today
Why Catalent Stock Surged Nearly 5% Higher Today
Why Catalent Stock Zoomed 12% Higher This Week
Earnings Summary: Highlights of Catalent’s Q1 2024 results
Why Novo Nordisk Stock Crushed the Market on Monday
Why Catalent Stock Soared Today
Earnings Summary: Catalent (CTLT) slips to a loss in Q2; revenue down 10%
Shareholder Alert: Robbins LLP Informs Investors of Class Action Against Catalent, Inc. (CTLT)
Moderna Hits a Short-Term Vaccine Manufacturing Delay, Still on Track for First 100 Million Doses by End of March
Catalent, inc (CTLT) Q4 2021 Earnings Call Transcript
Catalent, inc (CTLT) Q1 2022 Earnings Call Transcript
Catalent (CTLT) Q2 2022 Earnings Call Transcript
About · FAQs · StocksCafe © 2024 · Privacy · Terms